Safety of Topical Dermatologic Medications in Pregnancy

被引:0
|
作者
Patel, Viral M. [1 ]
Schwartz, Robert A. [1 ]
Lambert, W. Clark [1 ]
机构
[1] Rutgers New Jersey Med Sch, Newark, NJ 07103 USA
关键词
MATERNAL USE; TRETINOIN; PSORIASIS; MALFORMATIONS; DRUGS; ACID; ISOTRETINOIN; DICLOFENAC; LACTATION; MINOXIDIL;
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Dermatologic drugs should be employed with caution in women of childbearing age who are pregnant or considering pregnancy. Topical drugs have little systemic absorption. Therefore, they are deemed safer than oral or parenteral agents and less likely to harm the fetus. However, their safety profile must be assessed cautiously, as there is limited available data. In this article, we aggregate human and animal studies and provide recommendations on using topical dermatologic medications in pregnancy.
引用
收藏
页码:830 / 834
页数:5
相关论文
共 50 条
  • [1] Safety of dermatologic medications in pregnancy and lactation Part I. Pregnancy
    Murase, Jenny E.
    Heller, Misha M.
    Butler, Daniel C.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (03) : 401.e1 - 401.e14
  • [2] Safety of dermatologic medications in pregnancy and lactation: An update - Part I: Pregnancy
    Mcmullan, Patrick
    Yaghi, Marita
    Truong, Thu M.
    Rothe, Marti
    Murase, Jenny
    Grant-Kels, Jane M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (04) : 619 - 648
  • [3] Safety of Topical Medications for Scabies and Lice in Pregnancy
    Patel, Viral M.
    Lambert, W. Clark
    Schwartz, Robert A.
    INDIAN JOURNAL OF DERMATOLOGY, 2016, 61 (06) : 583 - 587
  • [4] Safety of dermatologic medications in pregnancy and lactation Part II. Lactation
    Butler, Daniel C.
    Heller, Misha M.
    Murase, Jenny E.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (03) : 426 - +
  • [5] Safety of dermatologic medications in pregnancy and lactation: An updated-Part II: Lactation
    Yaghi, Marita
    McMullan, Patrick
    Truong, Thu M.
    Rothe, Marti
    Murase, Jenny
    Grant-Kels, Jane M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (04) : 651 - 668
  • [6] Topical antiviral and antifungal medications in pregnancy: a review of safety profiles
    Patel, V. M.
    Schwartz, R. A.
    Lambert, W. C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (09) : 1440 - 1446
  • [7] Response to McMullan et al, "Safety of dermatologic medications in pregnancy and lactation: An Update- Part I: Pregnancy,"and Yaghi et al., "Safety of dermatologic medications in pregnancy and lactation: An Update- Part II: Lactation"
    Smith, Nicole A.
    Shaw, Katharina S.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (02) : e33 - e34
  • [8] Medicolegal aspects of prescribing dermatologic medications in pregnancy
    Gupta, Rishu
    Butler, Daniel
    Murase, Jenny
    Sharma, Priyank
    High, Whitney
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB78 - AB78
  • [9] TOPICAL MEDICATIONS DURING PREGNANCY
    ROBERT, E
    SCIALLI, AR
    REPRODUCTIVE TOXICOLOGY, 1994, 8 (03) : 197 - 202
  • [10] Response to Smith and Shaw "Response to "Safety of dermatologic medications in pregnancy and lactation: An update e Part 1: Pregnancy & Part 2: Lactation''''
    McMullan, Patrick
    Yaghi, Marita
    Truong, Thu M.
    Rothe, Marti
    Murase, Jenny
    Grant-Kels, Jane M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (02) : e35 - e36